WHO accuses China of withholding Covid-19 genetic data
The World Health Organization (WHO) says it is unable to concretely identify the origins of the virus that led to …
-
-
US trade tariffs and the potential impact on pharma supply chains
When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear, …
-
Vetter breaks ground on $285m US clinical manufacturing site
German contract development and manufacturing organisation Vetter Pharma has commenced construction of a new $285m clinical manufacturing facility in Des …
-
CKD anemia market expected to reach $5.3bn across the 7MM by 2034
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the …
-
FDA removes safety programme for CAR-T therapies to boost uptake
The US Food and Drug Administration (FDA) has removed the risk evaluation and mitigation strategies (REMS) requirements for all approved …
-
Sobi gains FDA approval for Gamifant to treat HLH/MAS
The US Food and Drug Administration (FDA) has approved Sobi's Gamifant (emapalumab) to treat adults and children with haemophagocytic lymphohistiocytosis …
-
Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn
Torrent Pharmaceuticals, headquartered in Gujerat, India, has signed definitive agreements for the acquisition of a controlling stake in JB Chemicals …
-
FDA approves label updates for BMS’ CAR T cell therapies
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates …
-
AI in drug discovery: from hypothetical to reality
AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to revolutionise how …
-
Viatris gains China approval for Yupelri to treat COPD
Theravance Biopharma’s partner Viatris has received China's National Medical Products Administration (NMPA) approval for Yupelri (revefenacin) inhalation solution for maintenance …
-
Novo Nordisk teams up with WeightWatchers in latest telehealth push
Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with …
-
Why can’t the US figure out weight loss drug prices?
“I'm in London, and I just paid for this damn fat drug I take. I said, it's not working. They …
-
Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies
Porton Advanced Solutions and EVA Pharma have signed a memorandum of understanding (MoU) to enhance the development and manufacturing capabilities …
-
Vor Bio back from brink with autoimmune drug deal rising to $4bn
A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from …
-
BioCity’s SC0062 gains NMPA breakthrough therapy designation
The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's endothelin receptor type A …
